glioblastoma
Johns Hopkins-Led Team Launches Startup to Tackle Breast Cancer, Glioblastoma Applications
The team published data on Monday highlighting its microfluidic chip's ability to help predict the clinical outcomes of glioblastoma patients.Â
The firm has begun a trial for tests in non-small cell lung cancer and malignant melanoma and plans to launch an additional trial in glioblastoma.
Kiyatec Raises $3M in Series B2 Funding Round
The firm will use the proceeds to further a validation study  tracking the ability of its cell culture assay to predict patient response to cancer therapies.
Wistar Institute Spinout Isoma Diagnostics Secures Seed Funding
Isoma, which launched last year, will use the funds to develop and clinically validate a molecular test for stratifying glioblastoma patients.
AroCell, Green Cross Cell Collaborate on Complementary Test Development
The two companies will work together to develop AroCell's TK 210 ELISA test for Green Cross Cell's therapeutic products and methods.Â
May 16, 2017